The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
Eli Lilly is stockpiling $1.5 billion worth of its oral obesity drug orforglipron to avoid the supply shortages that hampered early GLP-1 launches. With an expected FDA decision on April 10, the company aims for a swift global rollout against Novo Nordisk's Wegovy pill. This strategic move signals big changes in accessible weight loss therapy.
GLP-1 medications like Ozempic and Wegovy have surged in popularity for weight loss and Type II diabetes management, but celebrities are now sharing alarming side effects. Bunnie Xo revealed suicidal ideations after using one, while her husband Jelly Roll shed nearly 300 pounds naturally. This guide examines the risks and promotes healthier paths.
Telehealth giant Hims & Hers stirred controversy by launching a cheap compounded version of Novo Nordisk's Wegovy pill, only to yank it days later amid FDA crackdowns and lawsuits. This incident highlights the ongoing Wild West in the knockoff GLP-1 market, where unapproved compounded drugs flood the scene despite resolved shortages. Patients risk ineffective or unsafe products—here's what you need to know.
Novo Nordisk's lawsuit against Hims & Hers claims compounded semaglutide sales are illegal now that shortages ended. But is this about patient safety or enforcing high prices like $150/month for Wegovy pills versus $50 alternatives? Dive into how patents create artificial semaglutide shortages.
Comedian and influencer Aishwarya Mohanraj bravely shared that weekly Mounjaro injections helped her shed 22kg in just 6 months, from 74kg to 52kg, overcoming deep insecurities. Soha Ali Khan commended her candor, saying 'so finally someone said it' in an industry rife with simplified transformation tales. Learn the details and what Mounjaro means for weight loss.
In a refreshing moment of candor amid the Ozempic debate, Bollywood actress Soha Ali Khan has praised influencer Aishwarya Mohanraj for admitting her use of Mounjaro for weight loss. This celebrity endorsement underscores growing openness about GLP-1 medications in entertainment circles. Discover the science behind these drugs and their implications for metabolic health.
Telehealth firm Hims & Hers sparked chaos by launching a cheap compounded Wegovy pill, only to yank it days later amid FDA crackdowns and a Novo Nordisk lawsuit. This incident highlights the ongoing Wild West in the knockoff GLP-1 market. Despite resolved shortages for Wegovy and Zepbound, unregulated compounded drugs remain widely available.
GLP-1 weight-loss drugs weren't meant to change restaurant menus, but they're doing just that in Denver and beyond. With appetites reset by Ozempic and similar meds, spots like Olive & Finch are prioritizing protein-packed small plates over supersized servings. Here's how the GLP-1 era is reshaping everyday eating.
Eli Lilly reports Mounjaro sales skyrocketing to $7.4 billion in Q4 2026, driven by explosive GLP-1 demand. New 2026 research links tirzepatide to liver inflammation resolution and reduced heart failure risks. Meanwhile, UK regulators ban unauthorized social media promotions of these prescription drugs.
